verified SJR 1,267 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Expert Opinion on Investigational Drugs

Expert Opinion on Investigational Drugs is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 122. It has a price of 4000 €. It has an SJR impact factor of 1,267 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,267.

Expert Opinion on Investigational Drugs focuses its scope in these topics and keywords: treatment, potential, therapeutic, drug, development, inhibitor, inhibitors, investigational, androgenetic, roles, ...

ISSN: 1354-3784

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,267 Q1

H-index 122

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.000 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,267

H-index

122

Docs (year)

111

Docs 3y

330

Total refs

9619

Cites 3y

1336

Citable 3y

300

Cites/Doc 2y

4.32

Ref/Doc

86.66

Immediate OA

4000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antiviral therapy of influenza

Why are there no new antibiotics?

Cytokine networks in allergic lung inflammation: an opportunity for drug intervention

Cyclophosphamide for scleroderma interstitial lung disease

CT-2103: emerging utility and therapy for solid tumours

Ciclesonide: a novel inhaled corticosteroid

Changing trends in the treatment of dry-eye disease

Celecoxib for the treatment of atherosclerosis

Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections

Campylobacter vaccine development:a key to controlling enteric diseases

beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors

Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction

SHOW MORE ARTICLES

Apoptosis regulating proteins as targets of therapy for haematological malignancies

9th Annual Meeting of the Eating Disorders Research Society

Antimicrobial peptides: therapeutic potential for the treatment of Candida infections

Antifungal peptides: potential candidates for the treatment of fungal infections

Antibiotics in the treatment of acute exacerbations of chronic bronchitis

Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces

Anidulafungin: an echinocandin antifungal

Alzheimer's disease: future drug development and the blood-brain barrier

Alzheimer?s disease - current trends in basic and clinical research. Highlights from the 16th ECNP

Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia

Advances in vaccine delivery: transcutaneous immunisation

Addenda

FAQs

Expert Opinion on Investigational Drugs has an SJR of 1,267 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Expert Opinion on Investigational Drugs is 24%.

Expert Opinion on Investigational Drugs

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Opinion on Investigational Drugs?

What is the APC / publication cost?

What is the acceptance rate?